Business Context and Reporting Period
This Form 6-K is filed by Stellar Biotechnologies Inc. (noted as Edesa Biotech, Inc. in metadata) for the month of May 2012, dated June 20, 2012. The registrant is a foreign issuer filing under Form 20-F. The filing serves as a cover document for interim financial statements and management discussion and analysis.
Key Financial Metrics
The filing text provided does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the attached exhibits (Exhibit 99.1: Interim Financial Statements for the period ended February 29, 2012, and Exhibit 99.2: Management Discussion and Analysis) which are not included in the input text.
Material Changes
The filing text does not provide details on material changes versus prior periods. Such information is expected to be found in the attached Management Discussion and Analysis (Exhibit 99.2).
Guidance, Outlook, and Risks
No specific guidance, outlook, management commentary, risks, contingencies, or unusual items are detailed in the cover page text. The filing references certifications by the CEO and CFO (Exhibits 99.3 and 99.4) but does not summarize their content.
Investor Verification Checklist
- Verify the discrepancy between the metadata company name (Edesa Biotech, Inc.) and the registrant name on the form (Stellar Biotechnologies Inc.).
- Review Exhibit 99.1 for the actual interim financial statements for the period ended February 29, 2012.
- Examine Exhibit 99.2 for the Management Discussion and Analysis to obtain revenue, profit, and liquidity figures.
- Confirm the status of the CEO and CFO certifications referenced in Exhibits 99.3 and 99.4.